Exploring the Interaction between Fractional Exhaled Nitric Oxide and Biologic Treatment in Severe Asthma: A Systematic Review

Background: Fractional exhaled nitric oxide (FeNO) is a biomarker of airway inflammation associated with airway hyper-responsiveness and type-2 inflammation. Its role in the management of severe asthmatic patients undergoing biologic treatment, as well as FeNO dynamics during biologic treatment, is...

Descripción completa

Detalles Bibliográficos
Autores principales: Pianigiani, Tommaso, Alderighi, Lorenzo, Meocci, Martina, Messina, Maddalena, Perea, Beatrice, Luzzi, Simona, Bergantini, Laura, D’Alessandro, Miriana, Refini, Rosa Metella, Bargagli, Elena, Cameli, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952501/
https://www.ncbi.nlm.nih.gov/pubmed/36829959
http://dx.doi.org/10.3390/antiox12020400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952501/
https://www.ncbi.nlm.nih.gov/pubmed/36829959
http://dx.doi.org/10.3390/antiox12020400

Ejemplares similares